A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Deshmukh, Ajoy
- Bone Marrow Aspiration and Bone Marrow Biopsy in Hematological Malignancies - A 10 Year Clinicopathological Study
Authors
1 Department of Pathology, Mayo Institute of Medical Sciences, Gadia, Barabanki, Lucknow, Uttar Pradesh, IN
2 Department of Medicine, School of Medical Science and Research, Sharda Hospital, Greater Noida, Uttar Pradesh, IN
3 Department of Pathology, School of Medical Science and Research, Sharda Hospital, Greater Noida, Uttar Pradesh, IN
4 Department of Pathology, Santosh Medical College, Ghaziabad, Uttar Pradesh, IN
Source
International Journal of Contemporary Medicine, Vol 1, No 1 (2013), Pagination: 95-99Abstract
Introduction: Hematological malignancies may derive from either of the two major blood cell lineages- Myeloid and lymphoid cell lines. Lymphoma, lymphocytic leukemias and myeloma are from the lymphoid line, while acute and chronic myelogenous leukemia, myelodysplastic syndromes and myeloproliferative diseases are myeloid in origin.
Objectives : The present study (2002 - 2012) has been aimed to report our bone marrow aspiration and biopsy examination experience with one hundred seven (107) patients of hematological malignancies from North India. and compare the results of bone marrow aspirations with bone marrow biopsy.
Material and Methods: In our study we have included cases of hematological malignancies (Leukemia, Malignant Lymphoma and Multiple Myeloma). In each case serial bone marrow aspiration and biopsy were done before and after chemotherapy and radiotherapy. Aspirate particles, smears, touch imprints of the biopsy core and paraffin sections of the biopsy core were routinely examined.
Results: Out of these one hundred seven (107) cases of hematological malignancies, non-Hodgkin's lymphoma (NHL) were maximum thirty cases (28.03%), followed by chronic myeloid leukemia (CML) twenty cases (18.69%), acute lymphoblastic leukemia (ALL) fifteen cases (14.01%), acute myeloid leukemia (AML) twelve cases (11.21%), multiple myeloma (MM) eleven cases (10.28%), chronic lymphocytic leukemia (CLL) ten cases (09.34%), Hodgkin's lymphoma (HL) eight cases (07.47%) and hairy cell leukemia (HCL) one case (0.93%).
Conclusion: Hematological malignancies were more prevalent in males and more common in first and third decades of life followed by fifth decade In this study bone marrow aspiration was found adequate in hematological malignancies especially in leukemia. Trephine biopsy is essential for diagnosis, when a dry tap or bloody tap occurs as a result of fibrotic or very densely cellular bone marrow. There is virtually no contraindication to aspiration and needle biopsy of the bone marrow. In malignant lymphomas, which are infiltrating to bone marrow, bone marrow biopsy (BMB) was found superior to bone marrow aspiration (BMA) as well as bone marrow involvement is a less favorable prognostic sign than the patients without bone marrow involvement.
Keywords
Bone Marrow, Hematological Malignancies.
References
- Anna Carter, Irit Hocherman, Shai linn et al (1987): Prognostic significance of plasma cell morphology in multiple myeloma. Cancer (60):1060 – 1065.
- Barbara J. Bain, David M. Clark and Irn A. Lampert (1992): Bone marrow pathology. Blackwell scientific publications. Oxford.
- Burkhardt R., Frisch B., and Bartl R. (1982): Bone marrow biopsy in hematological disorders. J. Clin. Pathol. (35): 257 – 284.
- Clain A. et al (1965): Secondary malignant disease of bone. Br. J. Cancer (19): 15 – 29.
- Islam A., Bertha Frisch and Handerson E. S. (1989): Laboratory techniques: Plastic embedded core biopsy: A complimentary approach to bone marrow aspiration for diagnosing acute myeloid leukemia. J. Clin. Pathol. (42): 300 – 306.
- James E. Bearden, Gary A. Ratkin and Charles A. Coltman (1974): Comparison of diagnostic value of bone marrow biopsy and bone marrow aspiration in neoplastic diseases. J. Clin. Pathol. (27): 738 – 740.
- Michael A. Simon and Eugene J. Bartucci (1986): The search for the primary tumor in patients with skeletal metastasis of unknown origin. Cancer (58): 1088 – 1095.
- Robert W. Mckenna and Jose A. Hernandez (1988): Bone marrow in malignant lymphoma. Hematology/Oncology clinics in North America. 2 (4): 617 – 635.
- Stephen E. Jones, Saul A. Rosenberg and Henry S. Kaplan (1972): Non Hodgkin’s lymphoma. 1- Bone marrow involvement. Cancer. (5): 954 - 960.
- Wolf C. De Peeters (1991): Bone marrow trephine interpretation: Diagnostic utility and potential pitfalls. Histipathology 18: 489 – 483.
- Role of Bone Marrow Study in Malignant Disorders: A Clinicopathological Study of 185 Patients
Authors
1 Department of Pathology, Mayo institute of medical sciences, Gadia, Barabanki, Lucknow, Uttar Pradesh, IN
2 Department of Medicine, School of Medical Science and Research, Greater Noida, Uttar Pradesh, IN
3 Department of Pathology, Dr. B. R. Sur Homeopathic Medical College and Hospital and Research center, New Delhi, IN
4 Department of Pathology, School of Medical Science and Research, Greater Noida, Uttar Pradesh, IN
5 Santosh Medical College, Ghaziabad, Uttar Pradesh, IN
Source
International Journal of Contemporary Medicine, Vol 1, No 2 (2013), Pagination: 36-40Abstract
Introduction: Bone marrow is a reservoir of stem cells and is the site of origin of numerous primary hematological malignancies and is commonly infiltrated by malignant cells in non-hematological malignancies in advanced stages. Objectives: The present study (2002 - 2012) has been aimed to report our experience with one hundred eighty five (185) patients from North India. A comparative study of bone marrow aspiration (BMA) and bone marrow biopsy (BMB) was done simultaneously, where the clinical history was correlated before and after chemotherapy and radiotherapy. Material and Method: In our study we have included cases of malignant disorders (hematological malignancies and non-hematological malignancies). In each case bone marrow aspiration and biopsy were done before and after chemotherapy and radiotherapy. Aspirate particles, smears, touch imprints of the biopsy core and paraffin sections of the biopsy core were routinely examined. Results: In our study we have included cases of hematological malignancies (Leukemia, Multiple Myeloma and Malignant Lymphoma) and non-hematological malignancies (Carcinoma of Breast, Prostate, Lung, Kidney, Urinary bladder, GIT, Thyroid, Round cell tumors and Indeterminate tumors). In hematological malignancies, non-Hodgkin's lymphomas (NHL) were maximum thirty cases (28.03%) and hairy cell leukemia (HCL) one case (0.93%). In non-hematological malignancies or primary tumors, there were maximum cases of breast carcinoma, twenty four cases (30.76%) and minimum two cases of thyroid carcinoma (02.56%). Conclusion: Malignant disorders were more prevalent in males and were seen in all the age groups. In this study bone marrow aspiration was found adequate in hematological malignancies especially in leukemia. Bone marrow biopsy found to be more informative in lymphoma and Metastatic tumors Bone marrow involvement indicated poor prognosis in metastatic tumors except in seven cases (18.42%) of malignant lymphoma. There was no complication of the procedure even in cases of thrombocytopenia.Keywords
Bone Marrow, Hematological Malignancies, Non-Hematological MalignanciesReferences
- Barbara J. Bain, David M. Clark and Irn A. Lampert (1992): Bone marrow pathology. Blackwell scientific publications. Oxford.
- Clain A. et al (1965): Secondary malignant disease of bone. Br. J. Cancer (19): 15 – 29.
- Coleman RE, Smith P. and Rubens RD (1998): Clinical course and prognostic factors following bone recurrence from breast cancer. Br. J. of Cancer. 77 (2): 336 – 340.
- Gupta R., Parikh PM and Advani SH et al (1989): Hodgkin’s disease with bone marrow involvement. Indian J. Cancer. (26): 58 – 66.
- James E. Bearden, Gary A. Ratkin and Charles A. Coltman (1974): Comparison of diagnostic value of bone marrow biopsy and bone marrow aspiration in neoplastic diseases. J. Clin. Pathol. (27): 738 – 740.
- James N. Ingle, Douglass C. Tormey, Joan M. Bull and Richard M. Simon (1977): Bone marrow involvement in breast cancer. Effect on response and tolerance to combination chemotherapy. Cancer. (39): 104 – 111.
- Jerry Z. Finklestein, Henry Ekert et al (1970): Bone marrow metastasis in children with solid tumors. Amer. J. Dis. Child. (119): 49 – 52.
- Kjurkchiev G. and Valkov I (1998): Role of touch imprints and core biopsy for detection of tumor metastasis in bone marrow. Diag-Cytopathol. 18 (5): 323 – 324.
- Michael A. Simon and Eugene J. Bartucci (1986): The search for the primary tumor in patients with skeletal metastasis of unknown origin. Cancer (58): 1088 – 1095.
- Richard A. Savage, George C. Hoffman and Keren Shaker R.N. (1978): Diagnostic problems involved in detection of metastatic neoplasm of bone marrow aspirates compared with needle biopsy. American J. Clin. Pathol. (70): 623 – 627.
- Robert W. Mckenna and Jose A. Hernandez (1988): Bone marrow in malignant lymphoma. Hematology/Oncology clinics in North America. 2 (4): 617 – 635.
- Stephen E. Jones, Saul A. Rosenberg and Henry S. Kaplan (1972): Non-Hodgkin’s lymphoma. 1- Bone marrow involvement. Cancer. (5): 954 - 960.
- Wolf C. De Peeters (1991): Bone marrow trephine interpretation: Diagnostic utility and potential pitfalls. Histipathology 18: 489 – 483.